The drug for the treatment of multiple myeloma.
Acellbia® – the first Russian mAb biosimilar prescribed to patients with non-Hodgkin’s lymphoma and chronic lymphocytic leukemia.
The first Russian granulocyte colony stimulating factor. Prevention and treatment of neutropenia associated with chemotherapy and HIV therapy.
Potent tyrosine-kinase inhibitor used in the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia.
Prevention and treatment of lung cancer, breast cancer, ovarian cancer.
A highly efficient medicine of oral fluoropyrimidines group used in the treatment of breast cancer, stomach cancer and colorectal cancer.
Gemcitar ® (gemcitabine)
Used in the treatment of pancreatic cancer, lung cancer, bladder cancer.
Medicine of taxanes group used in the treatment of breast cancer, gastric cancer, non-small cell lung cancer.
Highly selective non-steroidal aromatase inhibitor used in the treatment of hormonepositive breast cancer.
The drug for the treatment of non-small cell lung and breast cancer.
Prescribed for treatment of ovarian cancer, lung cancer, cervical cancer, malignant tumors of the head and neck, transitional cell carcinoma of the bladder.
Prevention and treatment of nausea and vomiting during chemo-radiotherapy.
Zolerix® (zoledronic acid)
Used in the treatment of bone metastases and solid tumors, osteolytic lesions in multiple myeloma and hypercalcemia induced by malignant tumors, as well as in the treatment of osteoporosis.
The drug for the treatment of B-cell oncohematological diseases.
Antineoplastic chemotherapy drug, alkylating agent, used in the treatment of malignant glyomas and melanoma.
Nonsteroidal antiandrogen drug used in the treatment of prostate cancer.
Anti EGFR/HER3 bispecific